Because glucocorticoid-induced osteoporosis (GIOP) is becoming a more common issue in rheumatology practice, it is important for rheumatologists to understand anabolic and antiresorptive agents for treating GIOP. Would you prescribe anabolic therapy or antiresorptive agents as first-line treatment for patients with GIOP?